Cambridge Cognition is a leading brand that develops innovative products and services to improve our understanding and treatment of conditions affecting brain health. With a focus on research technology, they aim to enhance cognitive assessments and methods of administering them both at home and in clinical settings. At the core of their business is extraordinary accuracy, scientific discovery, and validation.

This ensures that clinical scientists and academic researchers can trust their products and services to help them achieve their study goals and objectives. Their digital assessments target specific cognitive domains and provide increased data points, making them more sensitive to subtle changes in cognition. Cambridge Cognition offers a range of solutions, including cognitive assessments, electronic questionnaires and scales, and decentralised clinical trial solutions.

They also specialize in drug development, providing comprehensive solutions for assessing the cognitive safety and efficacy of drugs. Additionally, their suite of healthcare technology solutions is designed to detect early signs of memory problems and assess cognitive performance in various settings. With Cambridge Cognition's technology, cognition can be accurately assessed anytime, anywhere, using mobile devices, tablets, browsers, and wearables.

Their products utilize touch and voice functionality, offering convenience and accessibility. Over the years, Cambridge Cognition has achieved significant milestones and collaborations. They have worked with top-ranking universities, facilitated research advancements, and supported global pharmaceutical companies in assessing the cognitive effects of drugs.

They have expanded their virtual clinical trial solutions and joined forces with Winterlight Labs to lead in voice and digital biomarkers for clinical trials. With a team of industry leaders and a commitment to excellence, Cambridge Cognition continues to drive innovation in brain health assessments and research technology